HomeSFOSF • OTCMKTS
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Previous close
$1.70
Year range
$1.50 - $2.24
Market cap
60.97B HKD
Avg Volume
35.00
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 10.45B | 12.30% |
Operating expense | 4.11B | -4.30% |
Net income | 785.84M | 55.43% |
Net profit margin | 7.52 | 38.49% |
Earnings per share | — | — |
EBITDA | 1.60B | 229.39% |
Effective tax rate | 15.05% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.63B | -1.12% |
Total assets | 115.26B | 4.06% |
Total liabilities | 56.07B | 2.35% |
Total equity | 59.19B | — |
Shares outstanding | 2.66B | — |
Price to book | 0.10 | — |
Return on assets | 2.03% | — |
Return on capital | 2.49% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 785.84M | 55.43% |
Cash from operations | 1.08B | 65.68% |
Cash from investing | 210.24M | 122.80% |
Cash from financing | -1.59B | 11.34% |
Net change in cash | -389.75M | 80.29% |
Free cash flow | -2.97B | 27.05% |
About
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Founded
1994
Website
Employees
39,309
